MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation
View abstract on PubMed
Summary
This summary is machine-generated.Human MARCH5, a mitochondria-localized E3 ubiquitin-protein ligase, is overexpressed in hepatocellular carcinoma (HCC). MARCH5 promotes HCC cell growth and metastasis by enhancing autophagy, suggesting it as a therapeutic target.
Area Of Science
- Mitochondrial biology
- Oncology
- Biochemistry
Background
- MARCH5 is a mitochondria-localized E3 ubiquitin-protein ligase crucial for mitochondrial dynamics.
- Mitochondrial dynamics imbalances are linked to cancer development.
- The role of MARCH5 in hepatocellular carcinoma (HCC) remains uncharacterized.
Purpose Of The Study
- To investigate the expression, function, and prognostic value of MARCH5 in HCC.
- To elucidate the mechanisms by which MARCH5 influences HCC progression.
Main Methods
- Assessed MARCH5 mRNA and protein expression in HCC cell lines and patient tissues.
- Conducted in vitro and in vivo assays to evaluate the effects of MARCH5 modulation on HCC cell behavior.
- Explored the underlying molecular mechanisms, including p53 ubiquitination and autophagy.
Main Results
- MARCH5 is significantly overexpressed in HCC and correlates with poor patient prognosis.
- MARCH5 overexpression promotes HCC cell proliferation, migration, and invasion.
- MARCH5 enhances autophagy by promoting p53 degradation, driving HCC malignancy.
Conclusions
- MARCH5 plays a critical oncogenic role in HCC.
- MARCH5 represents a potential therapeutic target for hepatocellular carcinoma treatment.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

